Objective: Interferon-inducible 16 (IFI16) is known to involve in p53-dependent tumour suppression and also the formation of inflammasome, which function, however, remains controversy during carcinogenesis as a pattern recognition receptor for tumour death-derived free DNA. In this study, we investigated the anti-tumour role of IFI16 in hepatocellular carcinoma (HCC). 
cell death protein 1 antibody underlines that immunotherapy could be good alternative strategy for the treatment of HCC. 4 Pathogen-associated molecular patterns (PAMPs) (eg LPS, flagellin, microbial/virus DNA and RNA) and danger-associated molecular patterns (DAMPs) released from damaged host cells (eg ATP, alarmins and hostderived DNA) are danger signals for host immunity and could be sensed by pattern recognition receptors (PRRs) including toll-like receptors, NOD-like receptor, RIG-I-like receptors and AIM2-like receptors. 5, 6 Many immune adjuvants for cancer-therapy are derived from PAMP or DAMP and interact with the deregulated PRRs on immunocytes or tumours, 7, 8 and some have been demonstrated to regulate anti-tumour immunity. 9, 10 As an AIM2-like receptor, the interferon-inducible 16 (IFI16) protein, on the one hand, can sense dsDNA from some viruses to activate STING-TBK1 pathway for the production of IFN-β for anti-virus defence 11 and on the other hand, it has also been uncovered to bind DNA and form an inflammasome-a cytoplasmic protein complex which induces pyroptosis and proteolytic maturation of inflammatory cytokines IL-1β and IL-
18.
12 Therefore, it is critical for the clearance of pathogens or damaged cells. However, the role of IFI16 during carcinogenesis is unclear.
Mounting evidences indicated that IFI16 has been demonstrated to enhance the activation of the known p53 target genes including p21, Hdm2 and bax to induce p53-mediated cell cycle arrest and apoptosis in human cancer cells. 13, 14 But IFI16 can also interact with metastasis-associated protein 1 to down-regulate of oestrogen receptor α, leading to the resistance of tamoxifen-induced growth inhibition. 15 Additionally, although IFI16-induced inflammasome promote the anti-virus immunity, the effects of inflammasome on many types of cancers remain controversy, including gastric cancer, colon cancer and melanoma and seem to be tissue specific. 16, 17 In this study, we here found that IFI16 was down-regulated in HCC and restored its expression of IFI16 in tumour cells could increase p53-dependent tumour inhibition. Moreover, IFI16-induced inflammasome was found to inhibit HCC growth and metastasis. These data indicated that IFI16 is a tumour suppressor during the development of HCC.
| MATERIALS AND METHODS

| Tumour samples, cell lines and reagents
To estimate the expression of IFI16, HCC tissues (n = 20) and corresponding relative-normal tissues (n = 20) were collected from Shandong 
| Immunohistochemistry
To determine the expression of IFI16, p53 and ki-67 in HCC tissues, 2-μm-thick, formalin-fixed and paraffin-embedded specimen sections were used. After the slides were incubated in xylene for 5 minutes, 100% ethanol was used for 10 minutes, 95% ethanol for 10 minutes. System kit (Dako, Glostrup, Denmark) was used for the DAB chromogen followed by nuclear staining using haematoxylin.
| RNA isolation and qRT-PCR
According to the standard RNA isolation protocol, total RNA from tissues or Huh-7 and SMMC-7721 cells was extracted using Trizol reagent 
| Western blots
According to the manufacturer's instructions, the whole cell protein extracts were prepared and were separated using sodium dodecyl sulphate polyacrylamide gel electrophoresis and 10% gel. Proteins were then transferred to a polyvinylidene difluoride membrane (Millipore, Bed-ford, MA, USA), according to the instruction manual. Filters were blocked overnight in 5% w/v low-fat dry milk in 10 mmol/L Tris-HCl, pH 7.5, 0.1 mol/L NaCl and 0.1% Tween-20 and incubated with primary antibodies overnight at 4°C. After washing with TBST buffer, the blots were then incubated with HRP-conjugated secondary antibody for 2 hours at room temperature. After washing with TBST buffer, the blots were visualized using the ECL-Plus reagent (Millipore, Billerica, MA, USA). GAPDH was used as the loading control in the Western blotting.
| Cell transfection
The Huh-7 and SMMC-7721 cells were seeded into 12-well plates and transfected with pcDNA3.1-IFI16 or negative control for indicated time at a concentration of 1 ng/mL by Lipofectamine 2000 (Invitrogen)
according to the manufacturer's instructions.
| CCK-8 assay
After transfection of IFI16 in 2 HCC cell lines for indicated time, the cells were harvested and washed with PBS and then cell counting kit-8 (Kumamoto, Japan) mixed with DMEM was used for cell viability assay, and the absorbance was measured at 450 nm by a microplate reader.
| Scratch wound assay and transwell assay
For the scratch wound assay, the Huh-7 and SMMC-7721 cells 
| Colony formation assay
The Huh-7 and SMMC-7721 cells with overexpressed expression of IFI16 were harvested and were re-suspended in complete medium containing 10% FBS and were seeded into 12-well plates for 10 days.
Using 0.1% crystal violet, cells fixed with methanol for 15 minutes were visualized under a dissection microscope (Olympus, Tokyo, Japan) and colonies consisting of 50 cells or more were counted.
| Flow cytometer assay
The cells were fixed in cold 70% ethanol at −20°C for 2 hours and then were treated with 10 mg/mL RNase and stained with 2 μL of annexin V mixed with 2 μL of propidium iodide (PI; eBioscience, San Diego, CA, USA) and were used according to the manufacturer's instructions and quantified by flow cytometry on a FACS Calibur instrument.
| ELISA
According to the manufacturer's instructions, the ELISA kit for IL-1β, IL-18 and LDH (eBioscience) were used. The absorbency was measured at 450 nm by microplate reader.
| Tumour model
To investigate the tumour suppressive role of IFI16 in vivo, 2 × 10 The inhibitor PFTα (1 mg/kg) and Ac-YVAD-CMK (10 mg/kg) were administrated intraperitoneally for 3 times, 5 days apart.
| Statistical analyses
The Unpaired t-tests or Mann-Whitney U tests were used to compare the 2 groups, and multiple group comparisons were analysed with oneway ANOVA. P < .05 was considered statistically significant. All experiments were performed at least 3 times.
| RESULTS
| The expression of IFI16 is down-regulated in hepatocellular carcinoma
To Figure 1D ). These data implicated that the function of IFI16 might be suppressed during the development of HCC.
| Restoration of IFI16 level in tumour cells induces apoptosis and impairs ability of migration
We next examined the assumption that restoration of IFI16 could 
| IFI16 activates p53/p21 signals for its antitumour effects in vitro
The activation of p53-mediated tumour suppression was reported to be regulated by IFI16, 13 thus, we further investigated the role of p53 signals in IFI16-induced tumour inhibition. We found that forced expression of IFI16 could promote the expression of p53 and, meanwhile, enhance its activation via phosphorylation at ser15. IFI16 also promoted the activation of p53 target genes p21 which was also a tumour suppressor and elevated the p21 level in Huh-7 and SMMC-7721 cells, which suggested that IFI16 was able to activate p53/p21 pathway for tumour elimination ( Figure 3A) .
Moreover, to define the anti-tumour role of IFI16/p53 signals, the inhibitor of p53 activation PFTα was used. Although overexpression of IFI16 induced significant apoptosis, the results showed that the treatment of PFTα could render tumour cells resistance to apoptosis ( Figure 3B ). Correspondingly, the cells treated with PFTα could also resist IFI16 overexpression-induced decreased colony formation ( Figure 3C ) and an ability of migration ( Figure 3D,E) . The results suggested that the activated p53 signal is indispensable for IFI16-induced tumour inhibition ( Figure 3F ).
| Inflammasome could be induced by IFI16 to increase apoptosis and impair ability of migration
Apart from the anti-tumour role of p53, the IFI16-induced inflammasome might also participate into this process, because IFI16-induced cell death would release DAMP such as ATP and tumour-derived DNA to activate the recruitment of inflammasome complex, leading to the pyroptosis-related cell death. Moreover, the constitutive level of inflammasome was also reported in cancer. 18 Therefore, we exam- 
| DISCUSSION
Currently, the treatments for HCC are limited including surgery, ra- weaker staining of IFI16 when compared to normal mammary duct epithelium with positive nuclear staining. 13 However, in ASC, increased expression of IFI16 protein in squamous cell carcinoma was associated with keratinocyte differentiation. 20 The expression of IFI16 oral cancer was found to be up-regulated to enhance cell growth by the activation of NF-kappa B signalling which prevented the apoptosis in OSCC cells. 21 We here found that HCC tissues harboured less level of IFI16 than normal tissues. The levels of IL-1β, IL-18 and LDH in supernatant of tumour cells were determined by ELISA. *P < .05, **P < .01, ***P < .001, data represent the means ± SD. Abbreviations: NC, negative control; LDH, lactate dehydrogenase contributed to the increased apoptosis, decreased colony formation and migration.
Taken together, we found that IFI16 restoration in vitro in HCC cell lines induced cell apoptosis and impaired its ability of colony formation and migration in p53-and caspase-1-dependent manner. Moreover, IFI16-related inflammasome functioned as anti-tumour role in HCC.
The results in vivo confirmed the tumour suppressive role of IFI16 in HCC.
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